Data from the Clinical Proteomic Tumor Analysis Consortium29 (CPTAC) (https://ualcan.path.uab.edu) confirmed these findings and showed significantly reduced PMCA4 both at the mRNA (The Cancer Genome Atlas, TCGA) and protein levels in luminal breast cancer types compared to normal breast tissue. The gene discussed is ATP2B4; the disease is breast cancer.